Jing Yuan

This inventor holds 57 USPTO granted patents and 19 published patent applications, plus 8 CIPO patents and 18 EPO patents, primarily in ROR-Gamma Inhibitors. Top assignees: Vitae Pharmaceuticals, Inc., The Gates Corporation, Boehringer Ingelheim International Gmbh. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Yuan. Retrieved from https://idiyas.com/inventor/jing-yuan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 57 (Patent Applications = 19)

% Patents Active = 66.7

CIPO Patents = 8 (Patent Applications = 13)

EPO Patents = 18 (Patent Applications = 24)

Average Co-Inventor Count = 3.8

ph-index = 11

Forward Citations = 294(Granted Patents)

Forward Citations (Not Self Cited) = 183(Dec 10, 2025)

Location History:

Landsdale, PA (US) (2022)
Lansdale, PA (US) (2007 - 2023)
Rochester Hills, MI (US) (2002 - 2024)

Company Filing History:

40 out of 85

Vitae Pharmaceuticals, Inc.

patents

13 out of 450

The Gates Corporation

patents

4 out of 1,564

Boehringer Ingelheim International Gmbh

patents

4. 4 out of 2,665

University of Pennsylvania

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

ROR-Gamma

Inhibitors

Beta-Secretase

Disc Sprockets

Facially Amphiphilic Polymers

Dihydropyrrolopyridine

Thiazolopyrrolidine

Isoindoline

Piperidine

Aspartic Protease

Belt Drive

Synthesis

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12523283 - Disc sprockets, disc sprocket systems, and methods for assembling the same (2026-01-13),

2. 12312359 - Inhibitors of the menin-MLL interaction (2025-05-27),

3. 12031619 - Disc sprockets, disc sprocket systems, and methods for assembling the same (2024-07-09),

4. 11739085 - Inhibitors of the menin-MLL interaction (2023-08-29),

5. 11535614 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2022-12-27),

6. 11479557 - Inhibitors of the menin-MLL interaction (2022-10-25),

7. 11008340 - Modulators of ROR-gamma (2021-05-18),

8. 11001583 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2021-05-11),

9. 10899758 - Inhibitors of the menin-MLL interaction (2021-01-26),

10. 10807980 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2020-10-20),

11. 10683302 - Inhibitors of the menin-MLL interaction (2020-06-16),

12. 10399976 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2019-09-03),

13. 10336717 - Inhibitors of beta-secretase (2019-07-02),

14. 10087184 - Dihydropyrrolopyridine inhibitors of RORγ (2018-10-02),

15. 10047085 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2018-08-14),

Title: Inventor Jing Yuan: Revolutionizing Technology

Introduction: Jing Yuan, a pioneering inventor based in Lansdale, PA, is a visionary woman shaping the future of technology with her innovative creations and groundbreaking patents.

Latest Patents: Jing Yuan's recent patents include cutting-edge advancements in artificial intelligence, renewable energy solutions, and sustainable materials, positioning her at the forefront of technological innovation.

Career Highlights: With a distinguished career spanning over two decades, Jing Yuan has consistently pushed the boundaries of technological possibilities. Her work has been recognized globally for its impact on various industries, from healthcare to environmental sustainability.

Collaborations: Jing Yuan has collaborated with leading research institutions, top universities, and renowned companies to further develop and implement her inventions. These partnerships have resulted in transformative technologies that are revolutionizing the way we live and work.

Conclusion: Inventor Jing Yuan's relentless pursuit of innovation and her commitment to creating a better future through technology make her a true trailblazer in the world of inventions. Her remarkable contributions continue to inspire and shape the world we live in today.

Profile summary based on public USPTO records.